Precision Medicine.
Precision Therapies.

Hummingbird Bioscience is leading a bold new way of engineering biotherapeutics that can define the future of precision medicine.

Building on our deep experience in biologics discovery and development, coupled with our proprietary linker-payload technologies, we are developing a pipeline of next-generation antibody-based therapeutics, including ADCs, giving hope to patients who do not respond to current treatments.


We focus on targets in cancer with strong biological rationale and clinical validation


We use our proprietary technology platforms to discover and engineer precision therapies with the potential for deep and durable responses

Clinical Trials

We design and execute global clinical trials to maximize probability of success and make new medicines available to patients as quickly as possible


Latest News